[1]
G. D'Amato, “Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review”, Multidiscip Respir Med, vol. 9, no. 1, Dec. 2019, doi: 10.4081/mrm.2014.411.